Annual General Meeting in ALK-Abelló A/S on 15 March 2017
Feb 14, 2017 13:15 pm UTC| Business
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): The annual general meeting of ALK-Abelló A/S will take place on Wednesday 15 March 2017 at 16:00 (CET) at ALK-Abelló A/S, 1 Bøge Allé, 2970 Hørsholm, Denmark. The agenda of the...
American Pathology Foundation (APF) Announces 2017 Coding and Practice Management Seminars
Feb 14, 2017 13:11 pm UTC| Business
LAGUNA BEACH, Calif., Feb. 14, 2017 -- The American Pathology Foundation (APF), a non-profit professional society devoted to the business and management of pathology, will offer an innovative new program and timely...
Feb 14, 2017 13:10 pm UTC| Business
Revenue: $190.5 million for the year; $49.7 million in Q4Adjusted EBITDA: $123.5 million for the year; $33.6 million in Q4$177.8 million net debt reduction in 2016 and 2017 YTD $100.0 million debt repaid in January...
Marine Harvest ASA (OSE:MHG, NYSE:MHG): Registration of share capital increase
Feb 14, 2017 13:09 pm UTC| Business
Reference is made to the stock exchange notice published by Marine Harvest ASA (the "Company") on 10 February 2017 regarding the conversion of EUR 6.3 million of the outstanding loan of the EUR 375 million convertible bond...
Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent
Feb 14, 2017 13:09 pm UTC| Business
BRIDGEWATER, N.J., Feb. 14, 2017 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that the United States Patent and...
Marine Harvest ASA (OSE:MHG, NYSE:MHG): Registration of share capital increase
Feb 14, 2017 13:09 pm UTC| Business
Reference is made to the stock exchange notice published by Marine Harvest ASA (the "Company") on 10 February 2017 regarding the conversion of EUR 6.3 million of the outstanding loan of the EUR 375 million convertible bond...
Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent
Feb 14, 2017 13:09 pm UTC| Business
BRIDGEWATER, N.J., Feb. 14, 2017 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that the United States Patent and...